Cerca una sperimentazione clinica
Altra/e opzione/i di ricerca
8 Risultato/i
Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
; Finanziato da un ente associato a IRDiRC = 
; Membro di una ERN = 
Sperimentazioni cliniche nazionali
GERMANIA
Nordrhein-Westfalen
BONN
ROCK-ALS: Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS -DE-
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
GERMANIA
Nordrhein-Westfalen
BONN
HCQ-chILD-EU: Hydroxychloroquine in pediatric ILD - START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group to evaluate the efficacy and safety of hydroxychloroquine (HCQ) (Phase II) - ES
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
Sperimentazioni cliniche internazionali
GERMANIA
Bayern
MÜNCHEN
ROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS
Klinikum rechts der Isar der Technischen Universität München
Neurologische Klinik und Poliklinik
GERMANIA
Berlin
BERLIN
ROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity
Charité - Universitätsmedizin Berlin
GERMANIA
Berlin
BERLIN
ROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neonatologie
GERMANIA
Niedersachsen
GÖTTINGEN
ROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS
Georg-August-Universität Göttingen
GERMANIA
Nordrhein-Westfalen
BONN
ROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
GERMANIA
Nordrhein-Westfalen
BONN